title: Reversible metastatic pulmonary calcification in a patient with multiple myeloma.
abstract: A-52-year-old patient presented with a 2-year history of multiple myeloma, recurrent episodes of hypercalcemia, and extensive bone involvement. She developed pulmonary infiltrates, initially misdiagnosed as interstitial pneumonia. High-resolution computed tomography and bone scintiscanning indicated pulmonary calcification, which was confirmed by a transbronchial biopsy. Cytostatic treatment of multiple myeloma in combination with repetitive i.v. administration of bisphosphonates over a period of 6 months led to a significant improvement of clinical symptoms. Regression of pulmonary infiltrates was demonstrated by chest radiograph and computed tomography. There are only a few reports on pulmonary calcification in patients with multiple myeloma; the condition was associated mostly with progressive disease, kidney failure, adult respiratory distress syndrome and bad prognosis. In our patient isolated calcification of the lungs without involvement of other organ systems was successfully treated. These findings suggest that interstitial pulmonary calcinosis in multiple myeloma can be reversed by normalization of serum calcium levels using bisphosphonates combined with cytostatic treatment.
authors.affiliation: Department of Medicine I, University of Ulm, Germany.
authors.forename: C K
authors.initials: CK
authors.lastname: Weber
authors.forename: J M
authors.initials: JM
authors.lastname: Friedrich
authors.forename: E
authors.initials: E
authors.lastname: Merkle
authors.forename: O
authors.initials: O
authors.lastname: Prümmer
authors.forename: A
authors.initials: A
authors.lastname: Hoffmeister
authors.forename: T
authors.initials: T
authors.lastname: Mattfeldt
authors.forename: N
authors.initials: N
authors.lastname: Frickhofen
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D002114:Calcinosis / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*; D000077268:Pamidronate; D011241:Prednisone / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D004164:Diphosphonates; D000077268:Pamidronate; D008558:Melphalan; D011241:Prednisone